CHRS Operating Cash Flow (Statement)
Coherus Oncology Inc · Operating Cash Flow (Statement)
CHRS Operating Cash Flow (Statement)
Latest reported-$243.92Mperiod ending
CHRS TTM Cash from Operations ($15.42M → -$243.92M)
TTM operating cash flow (statement)
High-resolution chart · PNG
CHRS operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -243,917,000 | |
| -170,573,000 | |
| -138,513,000 | |
| -90,189,000 | |
| -105,866,000 | |
| 500,000 | |
| -20,440,000 | |
| -61,985,000 | |
| -54,269,000 | |
| -152,918,000 | |
| -174,884,000 | |
| -261,900,000 | |
| -244,689,000 | |
| -255,811,000 | |
| -241,124,000 | |
| -193,493,000 | |
| -142,693,000 | |
| -92,844,000 | |
| -37,432,000 | |
| 48,014,000 | |
| 81,656,000 | |
| 142,035,000 | |
| 154,145,000 | |
| 138,731,000 | |
| 146,329,000 | |
| 98,815,000 | |
| 28,355,000 | |
| -36,718,000 | |
| -134,458,000 | |
| -182,665,000 | |
| -159,266,000 | |
| -141,825,000 | |
| -140,549,000 | |
| -160,593,000 | |
| -200,286,000 | |
| -257,256,000 | |
| -277,691,000 | |
| -249,506,000 | |
| -252,545,000 | |
| -160,086,000 | |
| -157,793,000 | |
| -151,244,000 | |
| -107,990,000 | |
| -146,842,000 | |
| -92,357,000 | |
| -71,734,000 | |
| -23,927,000 | |
| 14,344,000 | |
| 41,040,000 | |
| 37,225,000 | |
| 15,423,000 |